Company Registration No. 06178610 (England and Wales)
H & H COSMETIC MEDICINE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 APRIL 2024
PAGES FOR FILING WITH REGISTRAR
H & H COSMETIC MEDICINE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 4
H & H COSMETIC MEDICINE LIMITED
BALANCE SHEET
AS AT
28 APRIL 2024
28 April 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Stocks
3,000
5,000
Cash at bank and in hand
1,187
285
4,187
5,285
Creditors: amounts falling due within one year
3
(64,576)
(53,738)
Net current liabilities
(60,389)
(48,453)
Creditors: amounts falling due after more than one year
4
(7,794)
(13,749)
Net liabilities
(68,183)
(62,202)
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
(68,184)
(62,203)
Total equity
(68,183)
(62,202)
H & H COSMETIC MEDICINE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
28 APRIL 2024
28 April 2024
- 2 -

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 28 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 28 April 2025
Ms H Edwards
Director
Company Registration No. 06178610
H & H COSMETIC MEDICINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 APRIL 2024
- 3 -
1
Accounting policies
Company information

H & H Cosmetic Medicine Limited is a private company limited by shares incorporated in England and Wales. The registered office is 23 London Road, Downham Market, Norfolk, England, PE38 9BJ. The Business address is 20 Langland Place, Royden, Essex, CM19 5FS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The ongoing support given by the director and shareholders is not anticipated to end. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

 

 

1.3
Turnover

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

H & H COSMETIC MEDICINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 APRIL 2024
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
2
2
3
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
6,494
5,970
Trade creditors
2,976
2,695
Taxation and social security
4,882
-
0
Other creditors
50,224
45,073
64,576
53,738
4
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
7,794
13,749
2024-04-282023-04-29falsefalsefalse28 April 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMs H Edwards061786102023-04-292024-04-28061786102024-04-28061786102023-04-2806178610core:CurrentFinancialInstruments2024-04-2806178610core:CurrentFinancialInstruments2023-04-2806178610core:Non-currentFinancialInstruments2024-04-2806178610core:Non-currentFinancialInstruments2023-04-2806178610core:ShareCapital2024-04-2806178610core:ShareCapital2023-04-2806178610core:RetainedEarningsAccumulatedLosses2024-04-2806178610core:RetainedEarningsAccumulatedLosses2023-04-2806178610bus:Director12023-04-292024-04-28061786102022-04-292023-04-2806178610bus:PrivateLimitedCompanyLtd2023-04-292024-04-2806178610bus:FRS1022023-04-292024-04-2806178610bus:AuditExemptWithAccountantsReport2023-04-292024-04-2806178610bus:SmallCompaniesRegimeForAccounts2023-04-292024-04-2806178610bus:FullAccounts2023-04-292024-04-28xbrli:purexbrli:sharesiso4217:GBP